BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15172111)

  • 1. Interleukin-1beta up-regulates iron efflux in rat C6 glioma cells through modulation of ceruloplasmin and ferroportin-1 synthesis.
    di Patti MC; Persichini T; Mazzone V; Polticelli F; Colasanti M; Musci G
    Neurosci Lett; 2004 Jun; 363(2):182-6. PubMed ID: 15172111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceruloplasmin expression and its role in iron transport in C6 cells.
    Chang YZ; Qian ZM; Du JR; Zhu L; Xu Y; Li LZ; Wang CY; Wang Q; Ge XH; Ho KP; Niu L; Ke Y
    Neurochem Int; 2007 Apr; 50(5):726-33. PubMed ID: 17316903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine toxicity to oligodendrocyte precursors is mediated by iron.
    Zhang X; Haaf M; Todorich B; Grosstephan E; Schieremberg H; Surguladze N; Connor JR
    Glia; 2005 Nov; 52(3):199-208. PubMed ID: 15968631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of C6 glioblastoma cell ceruloplasmin expression by neighboring human brain endothelia-derived interleukins in an in vitro blood-brain barrier model system.
    McCarthy RC; Kosman DJ
    Cell Commun Signal; 2014 Oct; 12():65. PubMed ID: 25311416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of acute-phase response proteins in retinal Müller cells in diabetes.
    Gerhardinger C; Costa MB; Coulombe MC; Toth I; Hoehn T; Grosu P
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):349-57. PubMed ID: 15623795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased divalent metal transporter 1 expression might be associated with the neurotoxicity of L-DOPA.
    Chang YZ; Ke Y; Du JR; Halpern GM; Ho KP; Zhu L; Gu XS; Xu YJ; Wang Q; Li LZ; Wang CY; Qian ZM
    Mol Pharmacol; 2006 Mar; 69(3):968-74. PubMed ID: 16317110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of interleukin-1beta on neurotoxicity, cytokine induction and glial reaction in specific brain regions.
    Depino A; Ferrari C; Pott Godoy MC; Tarelli R; Pitossi FJ
    J Neuroimmunol; 2005 Nov; 168(1-2):96-110. PubMed ID: 16112750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceruloplasmin in neurodegenerative diseases.
    Texel SJ; Xu X; Harris ZL
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1277-81. PubMed ID: 19021540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of interleukin-1beta by interleukin-4 in lipopolysaccharide-treated mixed glial cultures: microglial-dependent effects.
    Cao L; Fei L; Chang TT; DeLeo JA
    J Neurochem; 2007 Jul; 102(2):408-19. PubMed ID: 17442043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of type I and type II interleukin-1 receptors in focal brain inflammation.
    Docagne F; Campbell SJ; Bristow AF; Poole S; Vigues S; Guaza C; Perry VH; Anthony DC
    Eur J Neurosci; 2005 Mar; 21(5):1205-14. PubMed ID: 15813930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.
    Nemeth E; Tuttle MS; Powelson J; Vaughn MB; Donovan A; Ward DM; Ganz T; Kaplan J
    Science; 2004 Dec; 306(5704):2090-3. PubMed ID: 15514116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells.
    Castro LM; Gallant M; Niles LP
    J Neurochem; 2005 Dec; 95(5):1227-36. PubMed ID: 16313512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells.
    Zawadzka M; Kaminska B
    Glia; 2005 Jan; 49(1):36-51. PubMed ID: 15390105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier.
    Wu LJ; Leenders AG; Cooperman S; Meyron-Holtz E; Smith S; Land W; Tsai RY; Berger UV; Sheng ZH; Rouault TA
    Brain Res; 2004 Mar; 1001(1-2):108-17. PubMed ID: 14972659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine rescues glioma cells from cytokine-induced death by interfering with the signaling network involved in nitric oxide production.
    Isakovic A; Harhaji L; Dacevic M; Trajkovic V
    Eur J Pharmacol; 2008 Sep; 591(1-3):106-13. PubMed ID: 18606162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunction of the retinal pigment epithelium with age: increased iron decreases phagocytosis and lysosomal activity.
    Chen H; Lukas TJ; Du N; Suyeoka G; Neufeld AH
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1895-902. PubMed ID: 19151392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expressed human divalent metal transporter 1 is involved in iron accumulation in MES23.5 cells.
    Xu HM; Jiang H; Wang J; Luo B; Xie JX
    Neurochem Int; 2008 May; 52(6):1044-51. PubMed ID: 18082289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of cyclooxygenase-2 by interleukin-1beta in colon carcinoma cells.
    Duque J; Díaz-Muñoz MD; Fresno M; Iñiguez MA
    Cell Signal; 2006 Aug; 18(8):1262-9. PubMed ID: 16326073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin and PAR-1-AP increase proinflammatory cytokine expression in C6 cells.
    Fan Y; Zhang W; Mulholland M
    J Surg Res; 2005 Dec; 129(2):196-201. PubMed ID: 16143343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glial cell ceruloplasmin and hepcidin differentially regulate iron efflux from brain microvascular endothelial cells.
    McCarthy RC; Kosman DJ
    PLoS One; 2014; 9(2):e89003. PubMed ID: 24533165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.